Abstract:Extracellular vesicles (EVs) have emerged as important carriers for intercellular communication and biological sources for diagnosis and therapeutics. Low efficiency in EV isolation from biofluids, however, severely restricts their downstream characterization and analysis. Here, we introduced a novel strategy for EV isolation from urine for prostate cancer diagnosis using bifunctionalized magnetic beads through high affinity Ti(IV) ions and the insertion of a phospholipid derivative, 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine, into the EV membrane synergistically. We demonstrated its efficient isolation of EVs from urine samples with low contamination, high recovery (>80%), and short separation time (within 1 h), resulting in the identification of 36,262 unique EV peptides corresponding to 3302 unique proteins and 3233 unique phosphopeptides representing 1098 unique phosphoproteins using only 100 μL and 5 mL urine samples, respectively. Coupled with trapped ion mobility spectrometry and parallel accumulation–serial fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics of urine samples from prostate cancer patients and healthy individuals revealed 121 upregulated phosphoproteins in cancer patients in contrast to the healthy group. These particular advantages indicate that the novel bifunctional material enables sensitive EV phosphoproteomic analysis for noninvasive biomarker screening and early cancer diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19400</a>.FTIR, zeta potential, and fluorescence characterization of the different MBs-based materials (Figure S1); size distribution characterization of EVs isolated using UC, TiMBs, and DspeMBs (Figure S2); whole proteome overlap among different methods and top proteins of exosome and the phosphopeptides analysis of different isolation methods (Figure S3); Pearson correlation of EV proteomes of the clinical urine samples (Figure S4); the interaction pathway of the upregulated phosphoproteins (Figure S5); fold increase in these 13 exosomal proteins and 3 free urine proteins from LC–MS data of different methods compared to the UC sample (Table S2); and the list of the cancer-associated upregulated phosphoproteins (Table S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_001.pdf">PDF</a>)LC–MS whole proteome analysis data of EVs isolated by different methods (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_002.xlsx">XLSX</a>)LC–MS phosphoproteome analysis data of EVs isolated by different methods (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_003.xlsx">XLSX</a>)LC–MS prostate cancer-specific EV phosphoproteins analysis data (Table S4) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_004.xlsx">XLSX</a>)Mobility resolution of phosphorylation site isomers in urine EVs from prostate cancer patients (Table S6) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_005.xlsx">XLSX</a>)This article has not yet been cited by other publications.

Metabolic landscaping of extracellular vesicles from body fluids by phosphatidylserine imprinted polymer enrichment and mass spectrometry analysis

Rapid Enrichment and Sensitive Detection of Extracellular Vesicles Through Measuring the Phospholipids and Transmembrane Protein in a Microfluidic Chip.

Multi-omics characterization of highly enriched human plasma extracellular vesicles

High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification

Recent technical advances to study metabolomics of extracellular vesicles

Mass spectrometry‐based extracellular vesicle micromolecule detection in cancer biomarker discovery: An overview of metabolomics and lipidomics

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

Selective Enrichment and Detection of PD-L1 Positive Extracellular Vesicles Derived from Human Plasma and Patient Derived Tumor Cells

Using Functionalized Liposomes to Harvest Extracellular Vesicles of Similar Characteristics in Dermal Interstitial Fluid

Multi-omics discovery of hallmark protein and lipid features of circulating small extracellular vesicles in humans

Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes

Extracellular vesicles as a promising source of lipid biomarkers for breast cancer detection in blood plasma

Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis

A fast and sensitive size-exclusion chromatography method for plasma extracellular vesicle proteomic analysis

Extracellular vesicles and their nucleic acids for biomarker discovery

Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high‐purity human blood extracellular vesicles

Comparison of proteomic landscape of extracellular vesicles in pleural effusions isolated by three strategies

Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis

A fast and sensitive size‐exclusion chromatography method for plasma extracellular vesicle proteomic analysis

A new integrated method for tissue extracellular vesicle enrichment and proteome profiling

Isolation of Small Extracellular Vesicles from a Drop of Plasma Via EXODUS and Their Fingerprint Proteomics Profiling by MALDI-TOF MS